Güllü I - Search Results

1

Weekly irinotecan in patients with metastatic colorectal cancer failing 5-fluorouracil-based chemotherapy: efficacy and prognostic factors.

Karaoğlu A, Yalcin S, Tekuzman G, Kars A, Celik I, Güler N, Ozişik Y, Türker A, Barişta I, Güllü I. Karaoğlu A, et al. Among authors: gullu i. Tumori. 2003 Mar-Apr;89(2):141-5. Tumori. 2003. PMID: 12841660

2

Biweekly irinotecan plus bolus 5-fluorouracil and folinic acid in patients with advanced stage colorectal cancer.

Yalcin S, Oksuzoglu B, Tekuzman G, Engin H, Celik I, Turker A, Barista I, Gullu I, Guler N, Altundag K, Ozisik Y, Kars A. Yalcin S, et al. Among authors: gullu i. Jpn J Clin Oncol. 2003 Nov;33(11):580-3. doi: 10.1093/jjco/hyg111. Jpn J Clin Oncol. 2003. PMID: 14711983

3

Increased mean corpuscular volume of erythrocytes during capecitabine treatment: a simple surrogate marker for clinical response.

Arslan C, Aksoy S, Dizdar O, Kurt M, Güler N, Ozisik Y, Güllü I, Altundag K. Arslan C, et al. Among authors: gullu i. Tumori. 2011 Nov-Dec;97(6):711-6. doi: 10.1177/030089161109700606. Tumori. 2011. PMID: 22322836

4

Long-term complications in Hodgkin's lymphoma survivors.

Kilickap S, Barista I, Ulger S, Celik I, Selek U, Güllü I, Yildiz F, Kars A, Ozisik Y, Tekuzman G. Kilickap S, et al. Among authors: gullu i. Tumori. 2012 Sep-Oct;98(5):601-6. doi: 10.1177/030089161209800510. Tumori. 2012. PMID: 23235755

5

Procarbazine, CCNU, vincristine combination in the treatment of brain tumors.

Güllü IH, Celik I, Tekuzman G, Altunbaş M, Güler N, Barişta I, Alkiş N, Yalçin S, Kars A, Baltali E, Kansu E, Firat D. Güllü IH, et al. Tumori. 1996 May-Jun;82(3):228-31. Tumori. 1996. PMID: 8693599

6

Ifosfamide and etoposide in previously treated patients with advanced breast cancer.

Kiraz S, Baltali E, Güler N, Barişta I, Benekli M, Celik I, Güllü IH, Kars A, Tekuzman G, Firat D. Kiraz S, et al. Among authors: gullu ih. Tumori. 1997 Mar-Apr;83(2):604-7. doi: 10.1177/030089169708300225. Tumori. 1997. PMID: 9226029

7

Treatment of advanced refractory sarcomas with ifosfamide and etoposide combination chemotherapy.

Yalçin S, Güllü I, Barişta I, Tekuzman G, Ozişik Y, Celik I, Kars A. Yalçin S, et al. Among authors: gullu i. Cancer Invest. 1998;16(5):297-302. doi: 10.3109/07357909809084647. Cancer Invest. 1998. PMID: 9627675 Clinical Trial.

8

Non-Hodgkin's lymphomas of the tonsil: a retrospective analysis of twenty-eight patients with primary tonsillary lymphoma.

Barişta I, Tekuzman G, Güllü I, Baltali E, Kars A, Ozişik Y, Güler N, Celik I, Atahan IL, Firat D. Barişta I, et al. Among authors: gullu i. Tumori. 1995 Jul-Aug;81(4):234-7. doi: 10.1177/030089169508100403. Tumori. 1995. PMID: 8540117

9

Modified ESHAP as salvage chemotherapy for recurrent or refractory non-Hodgkin's lymphoma: results of a single-center study of 32 patients. Modified etoposide, methylprednisolone, cytarabine and cisplatin.

Oztürk MA, Barişta I, Altundağ MK, Türker A, Yalçin S, Celik I, Güllü I, Güler N, Ozişik Y, Kars A, Kansu E, Baltali E, Tekuzman G. Oztürk MA, et al. Among authors: gullu i. Chemotherapy. 2002 Dec;48(5):252-8. doi: 10.1159/000066768. Chemotherapy. 2002. PMID: 12476042 Clinical Trial.

10

Salvage ifosfamide-doxorubicin chemotherapy in patients with recurrent nasopharyngeal carcinoma pretreated with Cisplatin-based chemotherapy.

Altundag K, Aksoy S, Gullu I, Altundag O, Ozyar E, Yalcin S, Cengiz M, Akyol F. Altundag K, et al. Among authors: gullu i. Med Oncol. 2004;21(3):211-5. doi: 10.1385/MO:21:3:211. Med Oncol. 2004. PMID: 15456947

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

120 results

Search Page

Filters